Cargando…

Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers

Cell lines are important tools for biological and preclinical investigation, and establishing their relationship to genomic alterations in tumors could accelerate functional and therapeutic discoveries. We conducted integrated analyses of genomic and transcriptomic profiles of 15 human papillomaviru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Hui, Yang, Xinping, Si, Han, Saleh, Anthony D., Xiao, Wenming, Coupar, Jamie, Gollin, Susanne M., Ferris, Robert L., Issaeva, Natalia, Yarbrough, Wendell G., Prince, Mark E., Carey, Thomas E., Van Waes, Carter, Chen, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280671/ https://www.ncbi.nlm.nih.gov/pubmed/30380422 http://dx.doi.org/10.1016/j.celrep.2018.10.007

Ejemplares similares

Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer
por: Pan, Cassie, et al.
Publicado: (2018)

NSD1 mutations by HPV status in head and neck cancer: differences in survival and response to DNA-damaging agents
por: Pan, Cassie, et al.
Publicado: (2019)

Selective antitumor activity of roscovitine in head and neck cancer
por: Gary, Cyril, et al.
Publicado: (2016)

TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
por: Freudlsperger, Christian, et al.
Publicado: (2012)

TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma
por: Hajek, Michael, et al.
Publicado: (2017)

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer
por: Schrank, Travis P., et al.
Publicado: (2022)

Global Genome Demethylation Causes Transcription-Associated DNA Double Strand Breaks in HPV-Associated Head and Neck Cancer Cells
por: Hajek, Michael, et al.
Publicado: (2020)

HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis
por: Pan, Cassie, et al.
Publicado: (2018)

Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
por: Nottingham, Liesl K., et al.
Publicado: (2013)

APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2019)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
por: Rehmani, Hina S., et al.
Publicado: (2020)

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)

Applications of radiomics in precision diagnosis, prognostication and treatment planning of head and neck squamous cell carcinomas
por: Haider, Stefan P., et al.
Publicado: (2020)

Direct Comparison of HPV16 Viral Genomic Integration, Copy Loss, and Structural Variants in Oropharyngeal and Uterine Cervical Cancers Reveal Distinct Relationships to E2 Disruption and Somatic Alteration
por: Schrank, Travis P., et al.
Publicado: (2022)

Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer
por: Yan, Bin, et al.
Publicado: (2013)

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches
por: Allen, Clint T., et al.
Publicado: (2015)

Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
por: Yan, Bin, et al.
Publicado: (2013)

CK2 Phosphorylates and Inhibits TAp73 Tumor Suppressor Function to Promote Expression of Cancer Stem Cell Genes and Phenotype in Head and Neck Cancer()()
por: Lu, Hai, et al.
Publicado: (2014)

Evaluation of Patient-Reported Delays and Affordability-Related Barriers to Care in Head and Neck Cancer
por: Lenze, Nicholas R., et al.
Publicado: (2021)

National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database
por: Schwam, Zachary G., et al.
Publicado: (2015)

Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
por: Morgan, Ethan L., et al.
Publicado: (2020)

Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
por: Elghouche, Alhasan, et al.
Publicado: (2016)

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma
por: Yan, Bin, et al.
Publicado: (2007)

Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status
por: Yan, Bin, et al.
Publicado: (2008)

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
por: Toni, Tiffany, et al.
Publicado: (2023)

YAP Dysregulation by Phosphorylation or ΔNp63-mediated Gene Repression Promotes Proliferation, Survival and Migration in Head and Neck Cancer Subsets
por: Ehsanian, Reza, et al.
Publicado: (2010)

Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
por: An, Yi, et al.
Publicado: (2021)

Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
por: Morgan, Ethan L., et al.
Publicado: (2023)

Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon
por: Clark, Emily S., et al.
Publicado: (2008)

Benign Aggressive Lesions of Femoral Head and Neck: Is Salvage Possible?
por: Panchwagh, Yogesh, et al.
Publicado: (2018)

Otolaryngology, Head and Neck Surgery
por: Yang, Tsung-Lin, et al.
Publicado: (2014)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Review
por: Desai, Neha, et al.
Publicado: (2023)

LIM-Only Protein 4 (LMO4) and LIM Domain Binding Protein 1 (LDB1) Promote Growth and Metastasis of Human Head and Neck Cancer (LMO4 and LDB1 in Head and Neck Cancer)
por: Simonik, Elizabeth A., et al.
Publicado: (2016)

Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
por: Hatakeyama, Hiromitsu, et al.
Publicado: (2010)

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
por: Ye, Wenda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pmc5sk4cku0hpjmhvhdad90t2g